XML 76 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed consolidated statements of stockholders’ (deficit) equity - USD ($)
$ in Thousands
Total
Previously Reported
Revision of Prior Period, Adjustment
Non-redeemable convertible preferred stock
Non-redeemable convertible preferred stock
Previously Reported
Non-redeemable convertible preferred stock
Revision of Prior Period, Adjustment
Common stock
Common stock
Previously Reported
Common stock
Revision of Prior Period, Adjustment
Additional paid-in capital
Additional paid-in capital
Previously Reported
Additional paid-in capital
Revision of Prior Period, Adjustment
Accumulated deficit
Accumulated deficit
Previously Reported
Accumulated deficit
Revision of Prior Period, Adjustment
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Previously Reported
Accumulated other comprehensive loss
Revision of Prior Period, Adjustment
Preferred stock, balance (in shares) at Dec. 31, 2021       122,564,333 [1] 137,765,828 (15,201,495)                        
Common stock, balance (in shares) at Dec. 31, 2021             2,817,498 [1] 3,166,949 (349,451)                  
Balance at Dec. 31, 2021 $ 3,020 [1] $ 3,020 $ 0 $ 189,881 [1] $ 189,881 $ 0 $ 0 [1] $ 2,610 $ (2,610) $ 148,850 [1] $ 146,240 $ 2,610 $ (325,268) [1] $ (325,268) $ 0 $ (10,443) [1] $ (10,443) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of stock options (in shares)             155,137                      
Exercise of stock options 141                 141                
Stock-based compensation 1,600                 1,600                
Foreign currency translation adjustment, net of tax (38)                             (38)    
Net loss (25,266)                       (25,266)          
Preferred stock, balance (in shares) at Jun. 30, 2022       122,564,333                            
Common stock, balance (in shares) at Jun. 30, 2022             2,972,635                      
Balance at Jun. 30, 2022 $ (20,543)     $ 189,881     $ 0     150,591     (350,534)     (10,481)    
Common stock, balance (in shares) at Dec. 31, 2022 113,335,530           113,335,530                      
Balance at Dec. 31, 2022 $ (5,914)           $ 11     381,274     (376,797)     (10,402)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Exercise of stock options (in shares) 1,486,404           1,453,474                      
Exercise of stock options $ 1,208                 1,208                
Issuance of common stock in connection with the Purchase Agreement (in shares)             13,239,654                      
Issuance of common stock in connection with the Purchase Agreement 15,683           $ 1     15,682                
Stock-based compensation 11,477                 11,477                
Short swing profit settlement 244                 244                
Foreign currency translation adjustment, net of tax (85)                             (85)    
Net loss $ (50,506)                       (50,506)          
Common stock, balance (in shares) at Jun. 30, 2023 128,028,658           128,028,658                      
Balance at Jun. 30, 2023 $ (27,893)           $ 12     $ 409,885     $ (427,303)     $ (10,487)    
[1] Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Merger.